NPS Reports Successful GATTEX(TM) Extension Study (PR Newswire via Yahoo! Finance)
NPS Pharmaceuticals, Inc. today reported positive top-line results from a 28-week blinded Phase 3-extension study of GATTEX for short bowel syndrome patients who are dependent upon parenteral nutrition .